KIR3DL2 is a coinhibitory receptor on Sézary syndrome malignant T cells that promotes resistance to activation-induced cell death.

Blood

Institut National de la Santé et de la Recherche Médicale U976, Onco-Dermatology, Immunology and Cutaneous Stem Cells, Paris, France University Paris Diderot, Sorbonne Paris Cité, Paris, France.

Published: November 2014

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-09-598995DOI Listing

Publication Analysis

Top Keywords

kir3dl2 coinhibitory
4
coinhibitory receptor
4
receptor sézary
4
sézary syndrome
4
syndrome malignant
4
malignant cells
4
cells promotes
4
promotes resistance
4
resistance activation-induced
4
activation-induced cell
4

Similar Publications

KIR3DL2 is a coinhibitory receptor on Sézary syndrome malignant T cells that promotes resistance to activation-induced cell death.

Blood

November 2014

Institut National de la Santé et de la Recherche Médicale U976, Onco-Dermatology, Immunology and Cutaneous Stem Cells, Paris, France University Paris Diderot, Sorbonne Paris Cité, Paris, France.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!